Factors influencing insulin acceptance among type 2 diabetes mellitus patients in a primary care clinic: A qualitative exploration

BMC Family Practice

Volumn 14, Issue , 2013, Pages

  Abu Hassan, Hasliza ^a   Tohid, Hizlinda ^b   Mohd Amin, Rahmah ^c   Long Bidin, Mohamed Badrulnizam ^d   Muthupalaniappen, Leelavathi ^b   Omar, Khairani ^e  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^c UNIVERSITI SULTAN ZAINAL ABIDIN   (Malaysia)

^d HOSPITAL KUALA LUMPUR   (Malaysia)

^e UNIVERSITI SAINS ISLAM MALAYSIA   (Malaysia)

Author keywords

Insulin; Insulin resistance; Qualitative research; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; FEMALE; HUMAN; INFORMATION PROCESSING; MALAYSIA; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT DEPARTMENT; PATIENT ATTITUDE; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; SELF CARE; SELF CONCEPT; SOCIAL STIGMA;

ADULT; AGED; AMBULATORY CARE FACILITIES; ATTITUDE TO HEALTH; DIABETES MELLITUS, TYPE 2; FEMALE; FOCUS GROUPS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALAYSIA; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PRIMARY HEALTH CARE; QUALITATIVE RESEARCH; SELF CARE; SELF EFFICACY; SOCIAL STIGMA;

EID: 84887835120     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-14-164     Document Type: Article

References (43)

1. A case for introducing insulin early in the treatment of type 2 diabetes mellitus. Westphal SA, Palumbo PJ, Insulin 2006 1 65 69 10.1016/S1557-0843(06) 80012-6 (Pubitemid 43960655)
2. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. Vinik A, Clin Ther 2007 29 1236 1253 10.1016/j.clinthera.2007.07.005 (Pubitemid 351172224)
3. The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modeling study. Goodall G, Sarpong EM, Hayes C, Valentine WJ, BMC Endocr Disord 2009 9 19 10.1186/1472-6823-9-19 19804622
4. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with type 2 diabetes: a population-based analysis in the UK. Rubino A, McQuay LJ, Gough SC, Kvasz M, Tennis P, Diabet Med 2007 24 1412 1418 10.1111/j.1464-5491.2007.02279.x 18042083 (Pubitemid 350179434)
5. Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy. Nichols GA, Koo YH, Shah SN, J Gen Intern Med 2007 22 453 458 10.1007/s11606-007-0139-y 17372792 (Pubitemid 46941217)
6. Addressing barriers to timely intensification of diabetes care: the relationship between clinical inertia and patient behaviour. Kruger D, Spollett G, Consultant 2009 49 7 20 S25
7. Addressing barriers to initiation of insulin in patients with type 2 diabetes. Peyrot M, Rubin RR, Khunti K, Prim Care Diabetes 2010 4 1 11 S18 20394886
8. A qualitative study on healthcare professionals' perceived barriers to insulin initiation in a multi-ethnic population. Lee YK, Lee PY, Ng CJ, BMC Fam Pract 2012 13 28 10.1186/1471-2296-13-28 22469132
9. Psychological insulin resistance: patient beliefs and implications for diabetes management. Brod M, Kongsø JH, Lessard S, Christensen TL, Qual Life Res 2009 18 23 32 10.1007/s11136-008-9419-1 19039679
10. Psychological insulin resistance: a critical review of the literature. Gherman A, Veresiu IA, Sassu RA, Schnur JB, Scheckner BL, Montgomery GH, Practical Diabetes Int 2011 28 3 125 128 10.1002/pdi.1574
11. United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. United Kingdom Prospective Diabetes Study Group, BMJ 1995 310 83 88 7833731
12. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV, Diabetes Care 2005 28 2543 2545 10.2337/diacare.28.10.2543 16186296 (Pubitemid 41384310)
13. Measuring psychological insulin resistance: barriers to insulin use. Larkin ME, Capasso VA, Chen CL, Mahoney EK, Hazard B, Cagliero E, et al. Diabetes Educ 2008 34 511 517 10.1177/0145721708317869 18535324
14. Acceptance of insulin therapy: a long shot? Psychological insulin resistance in primary care. Woudenberg YJC, Lucas C, Latour C, Scholte op Reimer WJM, Diabet Med 2012 29 6 796 802 10.1111/j.1464-5491.2011.03552.x 22150962
15. Psychological insulin resistance (PIR) among type 2 diabetes patients at public health clinics in federal territory of Malaysia. Nur Azmiah Z, Zulkarnain AK, Tahir A, Int Med J Malaysia 2011 10 2 7 12
16. Perceptions of insulin therapy amongst Asian patients with diabetes in Singapore. Wong S, Lee J, Kot Y, Chong MF, Lam CK, Tang WE, Diabetes Medicine 2011 28 206 211 10.1111/j.1464-5491.2010.03195.x
17. Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes and needs (DAWN) study. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, et al. Diabetes Care 2005 28 2673 2679 10.2337/diacare.28.11.2673 16249538 (Pubitemid 43951158)
18. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Karter AJ, Subramanian U, Saha C, Crosson JC, Parker MM, Swain BE, et al. Diabetes Care 2010 33 4 733 735 10.2337/dc09-1184 20086256
19. People with type 2 diabetes facing the reality of starting insulin therapy: factors involved in psychological insulin resistance. Bogatrean MP, Hâncu N, Practical Diabetes International 2004 21 7 247 252 10.1002/pdi.670 (Pubitemid 39307426)
20. What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Polonsky WH, Jackson RA, Clinical Diabetes 2004 22 147 150 10.2337/diaclin.22.3.147
21. Social stigma as a barrier to diabetes self-management: implications for multi-level interventions. Shiu AT, Kwan JJ, Wong RY, J Clin Nurs 2003 12 1 149 150 10.1046/j.1365-2702.2003.00735.x 12519263 (Pubitemid 37260035)
22. NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance. Hunt LM, Valenzuela MA, Pugh JA, Diabetes Care 1997 20 3 292 298 10.2337/diacare.20.3.292 9051375 (Pubitemid 27098212)
23. Factors associated with psychological insulin resistance in individuals with type 2 diabetes. Nam S, Chesla C, Stotts NA, Kroon L, Janson SL, Diabetes Care 2010 33 8 1747 1749 10.2337/dc10-0099 20435797
24. Experiences of people with type 2 diabetes who have changed from oral medication to self-administered insulin injections. Morris JE, Povey RC, Street CG, Pract Diabetes Int 2005 22 7 239 243 10.1002/pdi.829 (Pubitemid 47007762)
25. Exploring patients' perceptions for insulin therapy in type 2 diabetes: a Brazilian and Canadian qualitative study. Guimarães C, Marra CA, Gill S, Meneilly G, Simpson S, Godoy ALPC, et al. Patient Prefer Adherence 2010 4 171 179 20694179
26. "I take what I think works for me": a qualitative study to explore patient perception of diabetes treatment benefits and risks. Nair KM, Levine MAH, Lohfeld LH, Gerstein HC, Can J Clin Pharmacol 2007 14 2 251 e259 18000317
27. Experiences of patients with type 2 diabetes starting insulin therapy. Phillips A, Nurs Stand 2007 21 22 35 41 10.7748/ns2007.02.21.22.35.c4515
28. Merriam SB, Qualitative research: a guide to design and implementation-revised and expanded from qualitative research and case study applications in education San Francisco: Jossey-Bass 2009
29. The use of focus group methodology-with selected examples from sexual health research. Robinson N, J Adv Nurs 1999 29 4 90 5913
30. Patients' Perceptions of subcutaneous insulin in the OPTIMIZE study: a multicenter follow-up study. Cefalu WT, Mathieu C, Pandson J, Freemantle N, Gough S, Canovatchel W, Diabetes Technol Ther 2008 10 1 25 38 10.1089/dia.2008.0249 18275360
31. Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes. Snoek F, Skovlund SE, Pouwer F, BMC Health Qual Life Outcomes 2007 5 69 10.1186/1477-7525-5-69 (Pubitemid 351260313)
32. A multicenter, randomized, open-label, comparative, two-period cross over trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Korytkowski M, Bell D, Jacobsen C, Suwannasari R, Clin Ther 2003 25 2836 2848 10.1016/S0149-2918(03)80337-5 14693308 (Pubitemid 37510593)
33. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy. Rakel RE, Adv Ther 2009 26 9 838 846 10.1007/s12325-009-0061-2 19768641
34. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Graff MR, McClanahan MA, Clin Ther 1998 20 486 496 10.1016/S0149-2918(98)80058-1 9663364 (Pubitemid 28343501)
35. FlexPen: addressing issues of confidence and convenience in insulin delivery. Korytkowski M, Niskanen L, Asakura T, Clin Ther 2005 27 Suppl. B 89 S100 16519040
36. Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Brunton S, Am J Med 2008 121 35 S41 10.1016/j.amjmed.2008.03.025 18514089 (Pubitemid 351726337)
37. A discrete choice experiment evaluation of patients' preferences for different risk, benefit, and delivery attributes of insulin therapy for diabetes management. Guimarães C, Marra CA, Gill S, Simpson S, Meneilly G, Queiroz RHC, et al. Patient Prefer Adherence 2010 4 433 440 21301591
38. Quality of life and insulin therapy in type 2 diabetes mellitus. Funnell MM, Insulin 2008 3 1 31 36 10.1016/S1557-0843(08)80009-7 (Pubitemid 351343656)
39. The health belief model. Janz NK, Champion VL, Strecher J, Health behavior and health education: theory, research and practice San Fransisco: Jossey-Bass, Glanz K, Rimer BK, Lewis FM, 3 2002 45 66
40. Barriers to optimal control of type 2 diabetes in Malaysian Malay patients. Mohd Ali S, Jusoff K, Glob J Health Sci 2009 1 2 106 118
41. Barriers to insulin initiation and intensification and how to overcome them. Kunt T, Snoek FJ, Int J Clin Pract 2009 63 Suppl. 164 6 10
42. How to convince people with the 2 diabetes to start with insulin? Treatment options for patients with psychological insulin resistance. Küstner E, MMW Fortschr Med 2008 150 49 52
43. Health care and patient-reported outcomes-results of the cross-national diabetes attitudes, wishes and needs (DAWN) study. Rubin RR, Peyrot M, Siminerio LM, Diabetes Care 2006 29 1249 1255 10.2337/dc05-2494 16732004 (Pubitemid 44125918)